Free Trial
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel
OTCMKTS:AJINY

Ajinomoto 5/8/2025 Earnings Results & Report

Ajinomoto logo
$27.96 0.00 (0.00%)
As of 10/13/2026

Ajinomoto was expected to report earnings on May 8, 2025. Analysts expected earnings of $0.1118 per share on revenue of $2.62 billion. Confirmed results have not been posted yet. This page will update with the reported figures, conference call transcript, and earnings documents as they become available.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Announcement Date

Ajinomoto EPS Results

Actual EPS
N/A
Consensus EPS
$0.1118
Beat/Miss
N/A
One Year Ago EPS
N/A

Ajinomoto Revenue Results

Actual Revenue
N/A
Expected Revenue
$2.62 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Ajinomoto Earnings Headlines

Ajinomoto Co. Inc. Signals Confident FY 2025 Outlook
May 20, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/ajinomoto-co-inc-signals-confident-fy-2025-outlook?utm_source=marketbeat.com&utm_medium=referral
Ajinomoto Co. Inc. Earnings Call Signals Growth Ahead
May 6, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/ajinomoto-co-inc-earnings-call-signals-growth-ahead?utm_source=marketbeat.com&utm_medium=referral
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.tc pixel
October 14 at 1:00 AM  |  Awesomely (Ad)
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing
April 16, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/piramal-pharma-solutions-and-ajinomoto-bio-pharma-services-collaborate-to-support-adc-development-and-manufacturing-302744427.html
Is MSG Maker Ajinomoto Sitting on an AI Goldmine? This Investor Thinks So
April 10, 2026  |  wsj.comhttps://www.wsj.com/business/is-msg-maker-ajinomoto-sitting-on-an-ai-goldmine-this-investor-thinks-so-4a054b58
Ajinomoto Co. Inc ADR (AJINY)
April 8, 2026  |  nasdaq.comhttps://www.nasdaq.com/market-activity/stocks/ajiny/real-time
See More Ajinomoto Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ajinomoto? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ajinomoto and other key companies, straight to your email.

About Ajinomoto

Ajinomoto (OTCMKTS:AJINY) Co., Inc. is a Japan-based food and biotechnology company best known for its AJI-NO-MOTO brand monosodium glutamate and other seasonings. The company develops and sells flavorings, cooking products, processed and frozen foods, beverages, and nutrition-focused products for consumers, food-service operators, and food manufacturers.

Founded in 1909, Ajinomoto has expanded its expertise in amino acids and fermentation into businesses beyond traditional seasonings. Its activities include amino acid-based ingredients, health and nutrition products, pharmaceutical-related materials, and electronic materials used in semiconductor packaging and other applications.

Ajinomoto serves customers in Japan and international markets through a global network of manufacturing, research, and sales operations. The company is headquartered in Tokyo, Japan, and is led by President and Chief Executive Officer Taro Fujie.

View Ajinomoto Profile
Earnings Tools